STRYKER CORP 8-K

What Happened
Stryker Corporation filed a Form 8-K on March 23, 2026 (following prior notices on March 11 and March 12) to update investors about a cybersecurity incident. The company says it has worked with third‑party experts and law enforcement—including Palo Alto Networks’ Unit 42—to contain the incident, restore operations, and investigate the scope and impact. Investigators identified a malicious file used to run commands that hid the actor’s activity, but the file was not capable of spreading inside or outside Stryker’s environment. As of the filing date, Stryker’s investigation has not found evidence that the threat actor accessed customer, supplier, vendor or partner systems. The company reports disruption to its corporate network environment, including its Microsoft environment, and continues to assess operational and financial impact.

Key Details

• Filing: Form 8-K (Regulation FD Disclosure) filed March 23, 2026; earlier related 8-Ks filed March 11 and March 12, 2026.
• Third-party review: Investigation conducted with Palo Alto Networks Unit 42 and other experts; Unit 42 provided a General Assurance letter posted by Stryker.
• Technical finding: A malicious file was used to run commands and hide activity, but it could not propagate within or outside Stryker systems.
• Impact status: No evidence to date of malicious activity directed at customers, suppliers, vendors, or partners; disruption occurred to Stryker’s corporate (including Microsoft) environment; company has not determined whether the incident will have a material financial impact.

Why It Matters
This update matters to investors because cybersecurity incidents can affect operations, revenue timing, costs, and reputation. Stryker is still assessing the scope and potential financial impact, so there is uncertainty about whether the incident will be material to results. The company’s continued disclosure and third‑party review (Unit 42) are intended to provide assurance, but investors should monitor Stryker’s ongoing updates for any new findings or estimated impacts.